769 related articles for article (PubMed ID: 35095862)
21. CD40 Ligand-activated, antigen-specific B cells are comparable to mature dendritic cells in presenting protein antigens and major histocompatibility complex class I- and class II-binding peptides.
Ahmadi T; Flies A; Efebera Y; Sherr DH
Immunology; 2008 May; 124(1):129-40. PubMed ID: 18067555
[TBL] [Abstract][Full Text] [Related]
22. Intranasal administration of a synthetic peptide vaccine encapsulated in liposome together with an anti-CD40 antibody induces protective immunity against influenza A virus in mice.
Ninomiya A; Ogasawara K; Kajino K; Takada A; Kida H
Vaccine; 2002 Aug; 20(25-26):3123-9. PubMed ID: 12163263
[TBL] [Abstract][Full Text] [Related]
23. Cooperation of TNF family members CD40 ligand, receptor activator of NF-kappa B ligand, and TNF-alpha in the activation of dendritic cells and the expansion of viral specific CD8+ T cell memory responses in HIV-1-infected and HIV-1-uninfected individuals.
Yu Q; Gu JX; Kovacs C; Freedman J; Thomas EK; Ostrowski MA
J Immunol; 2003 Feb; 170(4):1797-805. PubMed ID: 12574344
[TBL] [Abstract][Full Text] [Related]
24. Direct T cell activation via CD40 ligand generates high avidity CD8+ T cells capable of breaking immunological tolerance for the control of tumors.
Soong RS; Song L; Trieu J; Lee SY; He L; Tsai YC; Wu TC; Hung CF
PLoS One; 2014; 9(3):e93162. PubMed ID: 24664420
[TBL] [Abstract][Full Text] [Related]
25. Enhancement of the priming efficacy of DNA vaccines encoding dendritic cell-targeted antigens by synergistic toll-like receptor ligands.
Grossmann C; Tenbusch M; Nchinda G; Temchura V; Nabi G; Stone GW; Kornbluth RS; Uberla K
BMC Immunol; 2009 Aug; 10():43. PubMed ID: 19650904
[TBL] [Abstract][Full Text] [Related]
26. Murine dendritic cells transfected with human GP100 elicit both antigen-specific CD8(+) and CD4(+) T-cell responses and are more effective than DNA vaccines at generating anti-tumor immunity.
Yang S; Vervaert CE; Burch J; Grichnik J; Seigler HF; Darrow TL
Int J Cancer; 1999 Nov; 83(4):532-40. PubMed ID: 10508491
[TBL] [Abstract][Full Text] [Related]
27. Development of a Novel CD4
Fernandez-Ruiz D; Lau LS; Ghazanfari N; Jones CM; Ng WY; Davey GM; Berthold D; Holz L; Kato Y; Enders MH; Bayarsaikhan G; Hendriks SH; Lansink LIM; Engel JA; Soon MSF; James KR; Cozijnsen A; Mollard V; Uboldi AD; Tonkin CJ; de Koning-Ward TF; Gilson PR; Kaisho T; Haque A; Crabb BS; Carbone FR; McFadden GI; Heath WR
J Immunol; 2017 Dec; 199(12):4165-4179. PubMed ID: 29084838
[TBL] [Abstract][Full Text] [Related]
28. Improved immunogenicity of a self tumor antigen by covalent linkage to CD40 ligand.
Huang HI; Wu PY; Teo CY; Chen MN; Chen YC; Silin D; Tao MH
Int J Cancer; 2004 Feb; 108(5):696-703. PubMed ID: 14696096
[TBL] [Abstract][Full Text] [Related]
29. CD40-CD40L cross-talk drives fascin expression in dendritic cells for efficient antigen presentation to CD4+ T cells.
Elizondo DM; Andargie TE; Kubhar DS; Gugssa A; Lipscomb MW
Int Immunol; 2017 Mar; 29(3):121-131. PubMed ID: 28369442
[TBL] [Abstract][Full Text] [Related]
30. Soluble multi-trimeric TNF superfamily ligand adjuvants enhance immune responses to a HIV-1 Gag DNA vaccine.
Kanagavelu SK; Snarsky V; Termini JM; Gupta S; Barzee S; Wright JA; Khan WN; Kornbluth RS; Stone GW
Vaccine; 2012 Jan; 30(4):691-702. PubMed ID: 22146759
[TBL] [Abstract][Full Text] [Related]
31. Fusion of Bacterial Flagellin to a Dendritic Cell-Targeting αCD40 Antibody Construct Coupled With Viral or Leukemia-Specific Antigens Enhances Dendritic Cell Maturation and Activates Peptide-Responsive T Cells.
Schmitt S; Tahk S; Lohner A; Hänel G; Maiser A; Hauke M; Patel L; Rothe M; Josenhans C; Leonhardt H; Griffioen M; Deiser K; Fenn NC; Hopfner KP; Subklewe M
Front Immunol; 2020; 11():602802. PubMed ID: 33281829
[TBL] [Abstract][Full Text] [Related]
32. Analysis of the CD40/CD40L role in the sustenance of alloreactive antibody production.
Shoker AS; Lun ZR; Choudry R; Saxena A
Transpl Immunol; 2001 Feb; 8(4):219-28. PubMed ID: 11316064
[TBL] [Abstract][Full Text] [Related]
33. Targeting dendritic cells in humanized mice receiving adoptive T cells via monoclonal antibodies fused to Flu epitopes.
Graham JP; Authie P; Yu CI; Zurawski SM; Li XH; Marches F; Flamar AL; Acharya A; Banchereau J; Palucka AK
Vaccine; 2016 Sep; 34(41):4857-4865. PubMed ID: 27595442
[TBL] [Abstract][Full Text] [Related]
34. Dendritic cells rapidly undergo apoptosis in vitro following culture with activated CD4+ Valpha24 natural killer T cells expressing CD40L.
Nieda M; Kikuchi A; nicol A; Koezuka Y; Ando Y; Ishihara S; Lapteva N; Yabe T; Tokunaga K; Tadokoro K; Juji T
Immunology; 2001 Feb; 102(2):137-45. PubMed ID: 11260318
[TBL] [Abstract][Full Text] [Related]
35. Mechanistic basis of co-stimulatory CD40-CD40L ligation mediated regulation of immune responses in cancer and autoimmune disorders.
Chand Dakal T; Dhabhai B; Agarwal D; Gupta R; Nagda G; Meena AR; Dhakar R; Menon A; Mathur R; Mona ; Yadav V; Sharma A
Immunobiology; 2020 Mar; 225(2):151899. PubMed ID: 31899051
[TBL] [Abstract][Full Text] [Related]
36. CD205 antigen targeting combined with dendritic cell recruitment factors and antigen-linked CD40L activation primes and expands significant antigen-specific antibody and CD4(+) T cell responses following DNA vaccination of outbred animals.
Njongmeta LM; Bray J; Davies CJ; Davis WC; Howard CJ; Hope JC; Palmer GH; Brown WC; Mwangi W
Vaccine; 2012 Feb; 30(9):1624-35. PubMed ID: 22240344
[TBL] [Abstract][Full Text] [Related]
37. Murine Fibroblastic Reticular Cells From Lymph Node Interact With CD4+ T Cells Through CD40-CD40L.
Nakayama Y; Brinkman CC; Bromberg JS
Transplantation; 2015 Aug; 99(8):1561-7. PubMed ID: 25856408
[TBL] [Abstract][Full Text] [Related]
38. Differential CD40/CD40L expression results in counteracting antitumor immune responses.
Murugaiyan G; Agrawal R; Mishra GC; Mitra D; Saha B
J Immunol; 2007 Feb; 178(4):2047-55. PubMed ID: 17277108
[TBL] [Abstract][Full Text] [Related]
39. Elicitation of both anti HIV-1 Env humoral and cellular immunities by replicating vaccinia prime Sendai virus boost regimen and boosting by CD40Lm.
Zhang X; Sobue T; Isshiki M; Makino S; Inoue M; Kato K; Shioda T; Ohashi T; Sato H; Komano J; Hanabusa H; Shida H
PLoS One; 2012; 7(12):e51633. PubMed ID: 23236521
[TBL] [Abstract][Full Text] [Related]
40. Trimeric HIV-1 gp140 fused with APRIL, BAFF, and CD40L on the mucosal gp140-specific antibody responses in mice.
Liu J; Clayton K; Gao W; Li Y; Zealey C; Budylowski P; Schwartz J; Yue FY; Bie Y; Rini J; Ostrowski M
Vaccine; 2020 Feb; 38(9):2149-2159. PubMed ID: 32014267
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
